These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 31887)

  • 1. Tetrahydroisoquinolines derived from catecholamines or DOPA: effects on brain tyrosine hydroxylase activity.
    Weiner CD; Collins MA
    Biochem Pharmacol; 1978; 27(23):2699-703. PubMed ID: 31887
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of tetrahydroisoquinolines with activated tyrosine hydroxylase.
    Bennett DB; Galloway MP; Coscia CJ
    Prog Clin Biol Res; 1982; 90():301-9. PubMed ID: 6125949
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of catecholic tetrahydroisoquinolines on endogenous catecholamines.
    Collins MA; Hannigan JJ; Weiner C
    Curr Alcohol; 1979; 5():53-9. PubMed ID: 755639
    [No Abstract]   [Full Text] [Related]  

  • 4. Confirmation of an unexpected brain O-methylation pattern for the dopamine-derived tetrahydroisoquinoline, salsolinol.
    Origitano TC; Collins MA
    Life Sci; 1980 Jun; 26(24):2061-5. PubMed ID: 7392819
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of dopamine and dopamine-derived tetrahydroisoquinolines on Ca++-Mg++-ATPase.
    Ross DH; Hamilton MG
    Prog Clin Biol Res; 1982; 90():289-99. PubMed ID: 6125948
    [No Abstract]   [Full Text] [Related]  

  • 6. Regional distribution and control of tyrosine hydroxylase activity in the quail brain.
    Baillien M; Foidart A; Balthazart J
    Brain Res Bull; 1999 Jan; 48(1):31-7. PubMed ID: 10210165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of rat brain catecholamine synthesis by administration of small doses of tyrosine and evidence for substrate inhibition of tyrosine hydroxylase activity by large doses of the amino acid.
    Badawy AA; Williams DL
    Biochem J; 1982 Jul; 206(1):165-8. PubMed ID: 6127072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of DL-3-(5-benzimidazolyl)-2-methylalanine on brain and heart catecholamines-I. Depleting effects.
    Zenker N; Morgenroth VH; wright J; King JW; Arnett CD
    Biochem Pharmacol; 1976 Mar; 25(5):585-9. PubMed ID: 8054
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of tetrahydroisoquinolinecarboxylic acids in tyrosine 3-monooxygenase.
    Galloway MP; Roth BL; Coscia CJ
    Arch Biochem Biophys; 1981 Jul; 209(2):620-7. PubMed ID: 6117253
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction of salsolinol and tetrahydropapaveroline with catecholamines.
    Melchior CL
    Alcohol Clin Exp Res; 1979 Oct; 3(4):364-7. PubMed ID: 391089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic properties of catecholamine-derived TIQ's and 7-O-methylated metabolites in neuronal systems.
    Cohen G; Mytilineou C
    Prog Clin Biol Res; 1982; 90():265-74. PubMed ID: 7111322
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytotoxicity of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines.
    Maruyama W; Takahashi T; Minami M; Takahashi A; Dostert P; Nagatsu T; Naoi M
    Adv Neurol; 1993; 60():224-30. PubMed ID: 8093579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetrahydroisoquinolines and the serotonergic system.
    Hannigan JJ; Collins MA
    Drug Alcohol Depend; 1979; 4(3-4):235-7. PubMed ID: 527478
    [No Abstract]   [Full Text] [Related]  

  • 14. Endogenous dopamine-derived neurotoxins and Parkinson's disease.
    Deleu D
    Acta Neurol Belg; 1998 Dec; 98(4):319-21. PubMed ID: 9922818
    [No Abstract]   [Full Text] [Related]  

  • 15. Catecholamines and the hydroxylation of tyrosine in synaptosomes isolated from rat brain.
    Karobath M
    Proc Natl Acad Sci U S A; 1971 Oct; 68(10):2370-3. PubMed ID: 4400211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous tetrahydroisoquinolines associated with Parkinson's disease mimic the feedback inhibition of tyrosine hydroxylase by catecholamines.
    Scholz J; Toska K; Luborzewski A; Maass A; Schünemann V; Haavik J; Moser A
    FEBS J; 2008 May; 275(9):2109-21. PubMed ID: 18355318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of some psychotropic drugs on tyrosine hydroxylase activity in different structures of the rat brain.
    Besson MJ; Cheramy A; Gauchy C; Musacchio J
    Eur J Pharmacol; 1973 May; 22(2):181-6. PubMed ID: 4146008
    [No Abstract]   [Full Text] [Related]  

  • 18. [Competitive inhibition of catechol-O-methyltransferase by the tetrahydroisoquinoline alkaloids salsolidine and 1-carboxysalsoline].
    Sanft K; Thomas H
    Z Naturforsch C J Biosci; 1989; 44(1-2):173-6. PubMed ID: 2490067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes.
    Musso NR; Brenci S; Setti M; Indiveri F; Lotti G
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3553-7. PubMed ID: 8855800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial cells are able to synthesize and release catecholamines both in vitro and in vivo.
    Sorriento D; Santulli G; Del Giudice C; Anastasio A; Trimarco B; Iaccarino G
    Hypertension; 2012 Jul; 60(1):129-36. PubMed ID: 22665130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.